Jul 19, 2014

CardioCell launches trial to assess stem cell therapy for chronic HF

CardioCell announced the initiation of a phase 2a trial of ischemia-tolerant mesenchymal stem cell therapy for patients with chronic HF due to nonischemic cardiomyopathy. READ FULL ARTICLE